Methods to assess the biodistribution of radiolabelled somatostatin analogues and treatment response of neuroendocrine tumours
Introduction: During the past decade, proof of the principle that somatostatin receptors can be successfully used for in vivo targeting of neuroendocrine tumours (NETs) has been provided. These tumours are imaged with 111Indium-pentetreotide and treated with 90Yttrium labeled somatostatin analogues....
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2004
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.679903 |